Trial · NCT00422058
Results by group264
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 264
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Body Weight at Week 20 | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | Baseline | 97.3 | Standard Deviation 12.3 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Lira 1.2 mg/Lira 3.0 mg | Baseline | 96.4 | Standard Deviation 13.4 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Lira 1.8 mg/Lira 3.0 mg | Baseline | 98.0 | Standard Deviation 12.5 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Lira 2.4 mg/Lira 3.0 mg | Baseline | 98.4 | Standard Deviation 13.1 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Liraglutide 3.0 mg | Baseline | 97.5 | Standard Deviation 13.8 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Orlistat | Baseline | 96.0 | Standard Deviation 11.7 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | Change at Week 20 | -3.0 | Standard Deviation 3.3 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Lira 1.2 mg/Lira 3.0 mg | Change at Week 20 | -5.1 | Standard Deviation 3.5 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Lira 1.8 mg/Lira 3.0 mg | Change at Week 20 | -5.9 | Standard Deviation 5.0 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Lira 2.4 mg/Lira 3.0 mg | Change at Week 20 | -6.6 | Standard Deviation 4.6 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Liraglutide 3.0 mg | Change at Week 20 | -7.6 | Standard Deviation 4.6 | kg |
| Mean Change From Baseline in Body Weight at Week 20 | Orlistat | Change at Week 20 | -4.4 | Standard Deviation 4.1 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | Baseline | 97.3 | Standard Deviation 12.3 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Lira 1.2 mg/Lira 3.0 mg | Baseline | 96.4 | Standard Deviation 13.4 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Lira 1.8 mg/Lira 3.0 mg | Baseline | 98.0 | Standard Deviation 12.5 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Lira 2.4 mg/Lira 3.0 mg | Baseline | 98.4 | Standard Deviation 13.1 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Liraglutide 3.0 mg | Baseline | 97.5 | Standard Deviation 13.8 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Orlistat | Baseline | 96.0 | Standard Deviation 11.7 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | Change at Week 104 | -5.4 | Standard Deviation 5.9 | kg |
| Mean Change From Baseline in Body Weight at Week 104 | Lira 1.2 mg/Lira 3.0 mg | Change at Week 104 | -4.9 | Standard Deviation 5.8 | kg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00422058/results